From Horizon Discovery
This application note from Horizon Discovery describes the importance of novel kinase fusion detection across cancer types, the challenges of detecting fusions with FISH and targeted RT-qPCR, the advantages of RNA profiling, and Horizon’s FFPE control material, containing 6 clinically relevant, cell-line derived, kinase-fusion RNA biomarkers.
Offered Free by: Horizon Discovery
See All Resources from: Horizon Discovery